Navigation Links
Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
Date:9/14/2009

MOUNTAIN VIEW, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache. Both AZ-104 dose groups trended towards statistical significance, but the study did not meet its primary endpoint, which was defined as pain-relief at the 2-hour time point, compared to placebo. There were no serious adverse events in the clinical trial, and AZ-104 was generally safe and well tolerated in this patient population.

"The failure to reach statistical significance on the primary endpoint is disappointing, as we were not able to reproduce the positive clinical findings from our AZ-104 Phase 2a proof-of-concept clinical trial," said James V. Cassella, PhD, Senior Vice President, Research and Development at Alexza. "Loxapine is a drug that had not been previously studied in migraine patients, except for our earlier proof-of-concept study. As part of our collaboration with Symphony Allegro, we initiated this migraine program in 2007 to investigate whether loxapine might be a viable product candidate for migraine, due to the scientific rationale that loxapine's primary mechanism of action (dopamine antagonism) has shown effectiveness in treating migraine."

"We continue to be impressed with Staccato's ability to safely and very accurately deliver a portfolio of drugs in a simple, one-breath, patient-controlled inhalation," said Thomas B. King, President and CEO of Alexza. "The uniqueness of our Staccato technology allows us to examine medicines for both known and new indications, and we will continue to do so in a patient setting. Not every clinical trial will necessarily have posit
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Radiology information ... is used to store, manipulate, and distribute patient ... patient tracking and scheduling system, result reporting, and ... with HIS and other databases improves the hospital ... patient scheduling, patient list management, radiology department workflow ...
(Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
(Date:12/19/2014)... and LYON, France , Dec. 19, ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ADOC) ... an ultra-rapid insulin, known as BioChaperone Lispro, for treatment ... BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology and ... and Adocia will develop BioChaperone Lispro with the goal ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... showed no consistent differences in bone mineral density ... Diskus 250/50 (fluticasone,propionate and salmeterol inhalation powder) and ... term use of Advair(R) in patients,with COPD, ... that data from a three-year study of patients ...
... BRANFORD, Conn., Oct. 29 CuraGen Corporation,(Nasdaq: ... announced today that Company executives will be holding ... on Monday, November 3, 2008,following the release of ... data from CuraGen,s Phase II clinical trial evaluating,CR011-vcMMAE ...
Cached Medicine Technology:Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 2Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 3CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 2
(Date:12/20/2014)... NY (PRWEB) December 20, 2014 The aftermath ... caused quite a stir, not only in Hollywood, but worldwide. ... December 18th , the ripples of that attack are starting ... very jobs at risk. But they are not the ... exposed could be in for some embarrassing times ahead, agents ...
(Date:12/20/2014)... 20, 2014 Parker & Sons, Inc. ... years of experience in contractor services announces reaching a ... for the homeowners of Arizona. Parker and Sons is ... contractor technicians that make customer service the number one ... Arizona and started with one service vehicle and has ...
(Date:12/19/2014)... 19, 2014 Sub Zero Ice Cream is ... blood drive Sunday the 28th from 2pm-6pm at the Expo ... Road in Sarasota, FL. , Inquiries regarding time slots and ... participating in the donating process, Sub Zero Ice Cream & ... custom ice cream. , About Sub Zero Ice Cream & ...
(Date:12/19/2014)... Canadian, OK (PRWEB) December 19, 2014 ... is home to Lake Eufaula, the state’s largest lake ... lovely lakeside town is home to a little more ... at 1:00 P.M. on Saturday, the 6th of December. ... made its way through downtown Eufaula on Main Street. ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- New research warns parents ... young lives at risk. Nearly half of teen drivers killed ... that were at least 11 years old and often lacked important ... Eighty-two percent of teen drivers killed in crashes were in ... six to 10 years old, 31 percent were in cars 11 ...
Breaking Medicine News(10 mins):Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Older Cars a Bad Choice for Younger Drivers 2
... The Second Harvest Food Bank of,Greater New Orleans ... to help feed local families, thanks to Smithfield Foods, ... initiative,led by celebrity cook Paula Deen., The tour,s ... to the,nation,s hungry families, including those in metropolitan New ...
... removal of a malignant tumor, the chance that cancer ... remains high. But new research from Tel Aviv University, ... those cancer cells from taking root again and ... A new study led by Prof. Shamgar Ben-Eliyahu, from ...
... kills more than 33,000 Americans per year, experts say ... say they,ve spotted several potential new drug targets for ... caused by a bacterial infection that enters the bloodstream, ... kills tens of thousands of Americans a year. , ...
... Over Serious, Ongoing Patient Care Problems Throughout ... System ... Vote - Overwhelming Yes, OAKLAND, Calif., Feb. 27 In the face of ... Health facilities in the Bay Area will vote this week,and next on whether to ...
... leave nation vulnerable to disease, bioterror and health, threats according to ... ... Public Health, WASHINGTON, Feb. 27 While natural disasters,the threat ... resources, the U.S. is facing a major public health,workforce crisis that could ...
... WASHINGTON, Feb. 27 The Association for,Professionals ... announced,that it has been selected by Blue ... a statewide effort to reduce healthcare-associated,infections (HAIs)., ... leading health organizations to expand,the Foundation,s innovative ...
Cached Medicine News:Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour To Feed New Orleans Families 2Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour To Feed New Orleans Families 3Health News:Stress and fear can affect cancer's recurrence 2Health News:Stress and fear can affect cancer's recurrence 3Health News:Research May Yield New Weapons Against Sepsis 2Health News:5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain 2Health News:5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain 3Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 3
... with elastic fabric, these head cap systems ... to begin testing. Each Electro-Cap System features ... International 10-20 System. When you place your ... using with your head cap system and ...
... Made with elastic fabric, these head ... you need to begin testing. Each Electro-Cap ... to the International 10-20 System. When you ... you are using with your head cap ...
... When testing takes you into the OR, ... added protection of Cadwells new shielded electrodes. Keeping ... bar, and paired disc electrode has a special ... from the damaging effects of 60-cycle interference. That ...
... (HA) orbital implant was conceived by Arthur ... after a comprehensive review of the literature ... manuscripts dating back to 1885 (Mules 1885). ... with the performance of contemporary implants, allowed ...
Medicine Products: